BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Neuron
,
Pharmacogenetics
,
Lovastatin
,
rs2300478
,
SLC12A1
,
Hepatitis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
glutamate biosynthetic process
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Frontal lobe
Occipital lobe
Temporal lobe
Frontal cortex
Midbrain
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Acute hepatic failure
Hepatic failure
Enteritis of small intestine
11p partial monosomy syndrome
Disease due to Togaviridae
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
BCL9 protein, human
niguldipine
roscovitine
PF 573228
A 443654
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
SUS1
jumu
SUPT16H
STXBP2
NR2E1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
S.cerevisiae gene expression in 165 deletion mutations of chromatin modifiers
Yeast harboring FAR1, BAR1, FUS3, and MSG5 knockouts and STE11-4 mutation
L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for glutamate biosynthetic process
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against …
Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 …
Tolerability and Efficacy of L-Serine in Patients With GRIN-related Encephalopathy
Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ